Print

Vanda Pharmaceuticals, Inc. (VNDA) to Participate in Two September Healthcare Investor Conferences  
8/27/2012 10:45:05 AM

WASHINGTON, Aug. 23, 2012 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that it will present at two upcoming healthcare investor conferences during September 2012.

Vanda will present at the Stifel Nicolaus 2012 Healthcare Conference, being held in Boston, Massachusetts, on Wednesday September 5, 2012 at 4:25 p.m. Eastern Time.

On Friday September 7, 2012 Vanda will present at the BioCentury NewsMakers in the Biotech Industry Conference in New York City at 2:00 p.m. Eastern Time.

Both conference presentations will be webcast live on Vanda's corporate website, where they will be archived for 30 days. To access the presentations, log on to http://www.vandapharma.com and click on the "Presentations" option in the Investor Relations section. Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Company Contact:

Cristina Murphy
Senior Communications Manager
Vanda Pharmaceuticals Inc.
(202) 734-3414
cristina.murphy@vandapharma.com

SOURCE Vanda Pharmaceuticals Inc.


//-->